Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder Mar 8, 2024 07:00AM
Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120 Jun 5, 2023 07:00AM
NEO Exchange Announces Eligibility In MSCI Indexes May 28, 2021 08:30AM
NEO Exchange Announces Inclusion in FTSE Russell Indexes Mar 22, 2021 08:00AM